Treatment of resistant lithium-induced nephrogenic diabetes insipidus and schizoaffective psychosis with carbamazepine.
A man with resistant lithium-induced nephrogenic diabetes insipidus and affective psychosis was successfully treated with carbamazepine. Carbamazepine may be appropriate for concurrently treating lithium-induced renal dysfunction and manic-depression in patients whose prognosis may be jeopardized by lithium discontinuation.
D000328:Adult; D002220:Carbamazepine / Q000627:therapeutic use*; D003919:Diabetes Insipidus / Q000139:chemically induced* / Q000188:drug therapy; D006801:Humans; D007674:Kidney Diseases / Q000139:chemically induced* / Q000188:drug therapy; D008094:Lithium / Q000009:adverse effects*; D016651:Lithium Carbonate; D008297:Male; D011618:Psychotic Disorders / Q000188:drug therapy*
D016651:Lithium Carbonate; D002220:Carbamazepine; D008094:Lithium